These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 9440958
21. [Tocolysis: dangerous for the infant? Apropos of 1 case and review of the literature]. Khelifati Y. J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):252-6. PubMed ID: 11398001 [Abstract] [Full Text] [Related]
23. [Use of Bufenine in threatened abortion and threatened preterm delivery]. Migliorini P, Vatteroni P. Minerva Ginecol; 1977 Jun; 29(6):519-24. PubMed ID: 22054 [No Abstract] [Full Text] [Related]
24. [Maternal complications of the treatment of threatened premature labor]. Thoulon JM, Domenichini Y, Beaune J. Rev Prat; 1984 Dec 21; 34(59):3315-9. PubMed ID: 6151740 [No Abstract] [Full Text] [Related]
25. [Tocolysis in preterm premature rupture of membranes (PPROM): nonsense?]. Vercoustre L. Gynecol Obstet Fertil; 2008 Mar 21; 36(3):334-7. PubMed ID: 18308610 [No Abstract] [Full Text] [Related]
26. Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. Plangger N, Rist L, Zimmermann R, von Mandach U. Eur J Obstet Gynecol Reprod Biol; 2006 Feb 01; 124(2):168-72. PubMed ID: 16051414 [Abstract] [Full Text] [Related]
27. [Initial experience with a tocolysis ward (author's transl)]. Reiffenstuhl G, Staudach A. Geburtshilfe Frauenheilkd; 1978 Oct 01; 38(10):868-72. PubMed ID: 29820 [Abstract] [Full Text] [Related]
28. [The use of beta adrenergic receptor stimulants in the prevention of premature labor and abortion]. Szönyi G, Adám J, Csáki G, Ba J. Orv Hetil; 1974 Jun 09; 115(23):1350-2. PubMed ID: 4151934 [No Abstract] [Full Text] [Related]
29. [Clinical experience with a treatment of threatened premature delivery with the aid of a beta-mimetic drug (author's transl)]. Fröhlich H. Z Geburtshilfe Perinatol; 1973 Aug 09; 177(4):251-62. PubMed ID: 4149063 [No Abstract] [Full Text] [Related]
37. [Prematurity and dysmaturity prevention program (PDP program)]. Saling E. Z Geburtshilfe Perinatol; 1972 Feb 09; 176(1):70-81. PubMed ID: 4401849 [No Abstract] [Full Text] [Related]
38. Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study. Finley J, Katz M, Rojas-Perez M, Roberts JM, Creasy RK, Schiller NB. Obstet Gynecol; 1984 Dec 09; 64(6):787-91. PubMed ID: 6150456 [Abstract] [Full Text] [Related]
39. [Risks and benefits of intravenous tocolysis in threatened premature labor with premature membrane rupture]. Ruckhäberle KE, Vogtmann C, Viehweg B. Zentralbl Gynakol; 1981 Dec 09; 103(23):1417-28. PubMed ID: 7331587 [No Abstract] [Full Text] [Related]
40. [Use of beta-mimetics in threatened abortion or premature labor]. J Gynecol Obstet Biol Reprod (Paris); 1977 Dec 09; 6(3):391-418. PubMed ID: 20460 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]